fda backs modified baxter pump chicago the food and drug administration has cleared a modified version of baxter international inc s colleague intravenous fluid pump another step in the process to return the product to the u s market baxter pulled the widely used pump from the market in amid a host of issues the company agreed with the fda last june on steps to resume sales and fix more than devices already on the market while the fda said the modified colleague pump has been "cleared for marketing " baxter must still undergo a "quality systems audit" required by the june consent decree 
